FRAT1 Activators represent a class of chemicals specifically designed to enhance the activity or expression of FRAT1, a key protein in the Wnt/β-catenin signaling pathway. This pathway is crucial for several cellular processes, such as proliferation, differentiation, and migration. These activators operate by either directly interacting with the FRAT1 protein, thereby boosting its stability or activity, or by indirectly influencing the cellular mechanisms regulating the expression of the FRAT1 gene. The indirect methods might include altering epigenetic markers, modulating the activity of enzymes that degrade FRAT1, or affecting upstream signaling pathways, culminating in an increase in FRAT1 levels.
The significance of FRAT1 Activators lies in their ability to modulate a critical cellular signaling pathway. By upregulating FRAT1, they significantly influence the Wnt/β-catenin pathway, which is not only vital in normal cellular functions but also plays a key role in various pathologies due to its involvement in cell growth and development. The chemical structures of FRAT1 Activators are diverse, ranging from small, specifically designed synthetic molecules to naturally occurring compounds that inadvertently modulate FRAT1 activity. This diversity is a testament to the complexity of the biological systems they are intended to influence. The development and research of FRAT1 Activators require an interdisciplinary approach, integrating molecular biology, chemistry, and bioinformatics, to effectively understand and manipulate the subtle yet profound aspects of cellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK-3β, a negative regulator in the Wnt/β-catenin pathway. This inhibition could lead to a feedback mechanism that upregulates FRAT1 expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As a histone deacetylase inhibitor, valproic acid may enhance FRAT1 gene transcription by increasing chromatin accessibility around the FRAT1 gene. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor might increase FRAT1 expression by reducing methylation at the FRAT1 gene promoter, enhancing gene transcription. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By increasing cAMP levels, forskolin might indirectly upregulate FRAT1 expression through various signaling pathways that intersect with the Wnt/β-catenin pathway. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A can promote FRAT1 expression by inhibiting histone deacetylase, thereby enhancing the accessibility of the FRAT1 gene for transcription. | ||||||
Biochanin A | 491-80-5 | sc-205603 sc-205603A | 100 mg 250 mg | $77.00 $132.00 | ||
As an isoflavone, biochanin A might interact with estrogen receptors, potentially leading to an upregulation of FRAT1 expression through interconnected signaling pathways. | ||||||